3874 completed, 1367 recruiting, 1367 unknown, 919 terminated. 2892 Phase 2, 2183 Phase 1, 1727 Not applicable, 620 Phase 3, 151 Early Phase 1.
Follow Endocrine Gland Neoplasms: new trials by email Literature Review of Endocrine Gland Neoplasms trials Research Report on Endocrine Gland Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC certepetide, nab-paclitaxel, gemcitabine - Pancreas Cancer, Pancreatic Carcinoma | Phase 1 / Phase 2 | Withdrawn | Lisata Therapeutics, Inc. | 2030-01-01 | 2025-06-06 | |
| Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors Exercise and dietary recommendations - Ovarian Cancer | Not applicable | Not yet recruiting | Oncare Madrid | 32 | 2028-05-01 | 2026-10-08 |
| Mapping Patient Decision-making in Thyroid Cancer Decision navigation tool - Thyroid Cancer | Not applicable | Not yet recruiting | University of California, Los Angeles | 50 | 2028-04-01 | 2026-07-24 |
| Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms Clinical Intervention or Procedure, Electronic Health Record Review, Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Pancreas - Pancreatic Neoplasm, Pancreatic Neuroendocrine Tumor | Not applicable | Enrolling by invitation | Ohio State University Comprehensive Cancer Center | 12 | 2027-10-01 | 2026-10-13 |
| Pre-Clinic Visit Online Education for Thyroid Cancer THRIVE, ACS "After a Thyroid Cancer Diagnosis" Flyer - Thyroid Cancer | Not applicable | Not yet recruiting | Cedars-Sinai Medical Center | 60 | 2027-08-01 | 2026-09-01 |
| Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC Rintatolimod - Pancreatic Cancer | Phase 2 | Suspended | AIM ImmunoTech Inc. | 90 | 2027-08-01 | 2026-08-19 |
| Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation DN022150+AG( Stage I ), DN022150+AG(Stage II), placebo+AG(Stage II) - Pancreatic Cancer, Pancreatic Carcinoma | Phase 2 / Phase 3 | Not yet recruiting | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 465 | 2027-06-06 | 2026-06-18 |
| Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 31 | 2027-06-01 | 2026-10-22 |
| Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery Indocyanine Green, Near-Infrared Fluorescence Imaging System - Gynecologic Cancers, Ovarian Cancer | Phase 4 | Not yet recruiting | Istanbul University | 50 | 2027-06-01 | 2026-11-18 |
| Daraxonrasib in Resectable PDAC Daraxonrasib, Surgical Resection, Adjuvant Chemotherapy - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer | Phase 1 | Not yet recruiting | Dana-Farber Cancer Institute | 30 | 2027-04-13 | 2026-10-27 |
| PITCH - Impacting Hereditary Cancer Testing Genetic testing education video - Ovarian Cancer, Genetic Testing | Not applicable | Not yet recruiting | Rachel Miller | 200 | 2027-04-01 | 2026-09-10 |
| A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer EF-009 - Pancreatic Cancer | Phase 1 / Phase 2 | Not yet recruiting | Everfront Biotech Co., Ltd. | 30 | 2027-04-01 | 2026-09-11 |
| A Prospective Study of Concurrent Hyperthermia, Chemotherapy and Radiotherapy in Borderline and Locally Advanced Pancreatic Cancer (PANHEAT) Hyperthermia plus neoadjuvant chemotherapy/radiotherapy Arm Description: Hyperthermia plus neoadjuvant chemotherapy (mFOLFIRINOX/nab Paclitaxel) followed by a) surgically resectable: Hyp - Borderline and Locally Advanced Pancreatic Cancer | Not applicable | Not yet recruiting | Fernando Pessoa Canarias University | 60 | 2027-03-31 | 2026-09-24 |
| A Study of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab as Maintenance Therapy in Second-Line Platinum-Sensitive Recurrent Ovarian Cancer (REJOICE-Ovarian03) R-DXd, Bevacizumab - Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 3 | Not yet recruiting | Daiichi Sankyo | 600 | 2027-03-31 | 2026-11-13 |
| STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL) Ivonescimab - Adrenocortical Carcinoma, Pheochromocytoma | Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 20 | 2027-02-07 | 2026-09-18 |
| Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer losartan, Paclitaxel - Platinum Resistant Ovarian Cancer | Phase 2 | Not yet recruiting | Massachusetts General Hospital | 27 | 2027-02-01 | 2026-09-22 |
| A Study of Perioperative Navlimetostat Combined With Modified FOLFIRINOX in Patients With MTAP-Deleted Pancreatic Cancer Navlimetostat, mFOLFIRINOX Treatment Regimen - Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 1 / Phase 2 | Not yet recruiting | Daniel Nussbaum, M.D. | 18 | 2027-01-15 | 2026-11-02 |
| Helping Young People With Testicular Cancer Using Virtual and Extended Reality Digital tool using extended reality - Testicular Cancer, Testis Cancer | Not applicable | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 245 | 2027-01-04 | 2026-05-06 |
| Predicting Pancreatic Fistula After Pancreatic Surgery Using Preoperative Immunity blood sampling - Pancreatic Cancer | Not yet recruiting | Institut Paoli-Calmettes | 310 | 2027-01-04 | 2026-09-18 | |
| Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules Diagnostic DNA Methylation Signature - Thyroid Gland Nodule | Recruiting | City of Hope Medical Center | 22 | 2027-01-01 | 2026-06-02 |
Showing 20 of 8889. Sign in to see all of them.
Pancreatic Neoplasms (3688) · Ovarian Neoplasms (3276) · Breast Neoplasms (883) · Carcinoma, Ovarian Epithelial (787) · Fallopian Tube Neoplasms (783) · Thyroid Neoplasms (722) · Neoplasms (679) · Colorectal Neoplasms (626) · Stomach Neoplasms (541) · Carcinoma, Non-Small-Cell Lung (538) · Endometrial Neoplasms (474) · Lung Neoplasms (445) · Uterine Cervical Neoplasms (395) · Neoplasm Metastasis (391) · Prostatic Neoplasms (351)
Endocrine System Diseases (8864) · Neoplasms by Site (8854) · Neoplasms (8210) · Digestive System Diseases (4431) · Digestive System Neoplasms (4390) · Urogenital Diseases (4112) · Urogenital Neoplasms (4034) · Genital Diseases (4006) · Female Urogenital Diseases (3900) · Female Urogenital Diseases and Pregnancy Complications (3900) · Gonadal Disorders (3868) · Pancreatic Diseases (3842) · Genital Diseases, Female (3734) · Genital Neoplasms, Female (3707)
Gemcitabine (814) · Paclitaxel (422) · Carboplatin (404) · Bevacizumab (268) · 130-nm albumin-bound paclitaxel (226) · Fluorouracil (215) · Cisplatin (211) · Oxaliplatin (207) · pembrolizumab (199) · Albumin-Bound Paclitaxel (186) · Capecitabine (162) · Cyclophosphamide (157) · Leucovorin (152) · Taxes (147) · Irinotecan (130)
National Cancer Institute (NCI) (347) · M.D. Anderson Cancer Center (176) · Memorial Sloan Kettering Cancer Center (162) · Mayo Clinic (82) · Fudan University (78) · Gynecologic Oncology Group (76) · AstraZeneca (71) · Dana-Farber Cancer Institute (70) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (61) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (61) · Peking Union Medical College Hospital (60) · Eli Lilly and Company (57) · University Health Network, Toronto (57) · Massachusetts General Hospital (50) · City of Hope Medical Center (49)
United States (4206) · China (1183) · France (655) · Italy (617) · Canada (567) · United Kingdom (527) · Spain (511) · South Korea (443) · Germany (441) · Belgium (332) · Australia (326) · Netherlands (313) · Denmark (229) · Japan (229) · Taiwan (202)
Lei Li, M.D. (14) · Paul Sabbatini, MD (13) · Saleh K Saleh, MD (13)
PMID 37185961, PMID 37407274, PMID 39863139, PMID 35170751, PMID 33337539, PMID 39695768, PMID 40668552, PMID 19238149, PMID 22551107, PMID 30633128, PMID 37598000, PMID 20818904, PMID 21561347, PMID 23433878, PMID 23922302, PMID 24131140, PMID 26961146, PMID 28733257, PMID 29342393, PMID 35537408, PMID 36512649, PMID 37934000, PMID 39019698, PMID 41044356, PMID 15273542, PMID 15855973, PMID 16394300, PMID 21420083, PMID 21941283, PMID 22154461, PMID 23547081, PMID 25968622, PMID 26707054, PMID 28040257, PMID 31401903, PMID 32379297, PMID 35262624, PMID 35397664, PMID 40056080, PMID 40132910, PMID 40341199, PMID 42836590, PMID 12826431, PMID 15908661, PMID 16172198, PMID 16882940, PMID 16966687, PMID 17000396, PMID 17554118, PMID 17949799
U10CA027469 (56), 2023 (54), U10CA180868 (42), 2016 (36), 2025 (36), 2018 (33), P30CA033572 (31), 2015 (29), 2017 (29), P30CA015083 (29), P30CA016672 (25), 2019 (24), 2014 (23), 2008 (21), 2009 (20)